OTCMKTS:IYXI

Inyx Stock Forecast, Price & News

$0.0002
0.00 (0.00 %)
(As of 09/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
$0.01
VolumeN/A
Average Volume30,534 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.76
30 days | 90 days | 365 days | Advanced Chart
Receive IYXI News and Ratings via Email

Sign-up to receive the latest news and ratings for Inyx and its competitors with MarketBeat's FREE daily newsletter.


About Inyx

Inyx, Inc. is pharmaceutical company, which develops and acquires niche pharmaceutical products and drug delivery systems for key therapeutic areas, including respiratory and dermatological applications. The company was founded in March 2000 and is headquartered in New York, NY.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Inyx (OTCMKTS:IYXI) Frequently Asked Questions

What stocks does MarketBeat like better than Inyx?

Wall Street analysts have given Inyx a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Inyx wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Inyx's key executives?

Inyx's management team includes the following people:
  • Mr. Steven Handley, Pres & Director (Age 57)
  • Mr. Jay M. Green, Exec. VP, Director of Corp. Devel. & Director (Age 71)
  • Ms. Carole Richardson, Corp. Admin. Mang. of Inyx Pharma Ltd.
  • Mr. William Kelly, VP of Corp. Communications & Investor Relations
  • Mr. Stephen Beckman, VP of Sales & Marketing and Commercial Devel. (Age 54)
  • Norma Rosa, Head of Fin. - Inyx USA Inc
  • Mr. Tony Weeks, Head of Operations - Ashton Pharmaceuticals Ltd
  • Mr. Eddie Prady, Head of Quality - Ashton Pharmaceuticals Ltd
  • Dr. Ulrich Bartke Ph.D., VP of Global Sales & Marketing (Age 64)

Who are some of Inyx's key competitors?

What is Inyx's stock symbol?

Inyx trades on the OTCMKTS under the ticker symbol "IYXI."

How do I buy shares of Inyx?

Shares of IYXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inyx's stock price today?

One share of IYXI stock can currently be purchased for approximately $0.00.

How many employees does Inyx have?

Inyx employs 572 workers across the globe.

What is Inyx's official website?

The official website for Inyx is www.inyxgroup.com.

Where are Inyx's headquarters?

Inyx is headquartered at 825 THIRD AVENUE, NEW YORK NY, 10022.

How can I contact Inyx?

Inyx's mailing address is 825 THIRD AVENUE, NEW YORK NY, 10022. The company can be reached via phone at (212) 838-1111 or via email at [email protected].


This page was last updated on 9/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.